In contrast to cancer treatment, where immunostimulatory effects are desirable, the treatment of autoimmune diseases with IL-2 should be focused on enhancing its immunosuppressive effects, while minimizing its immunostimulatory effects (Fig. 10a). The gene discussed is IL2; the disease is cancer.